Shara, who is an alumnus of Y Combinator, has done her BA & BBA, Business Honours Program & Plan II, from The University of Texas, Austin. She has also done her MBA from Harvard Business School. She was an analyst at Goldman Sachs prior to launching C16 Biosciences.
Harry has a Master’s Degree in Bioengineering from Trinity College, Dublin, and he is also a Doctor of Philosophy in Health Sciences & Technology from MIT, along with a PhD in Physics from Harvard. He has been recognised as a NDSEG Fellow, and received Purcell Fellowship, George J Mitchell Scholarship and Gates Cambridge Scholarship.